There were 255 more principal investigators funded for cancer research projects in 2010 than six years earlier, according to data gathered by the Canadian Cancer Research Survey and just released in the Cancer Research Investment in Canada, 2010 report.
“Unique to this report is our analysis of researcher capacity,” says Dr. Elizabeth Eisenhauer, Head, Department of Oncology at Queen’s University, Program Medical Director for Oncology at Kingston General Hospital, and Expert Lead for Research at the Partnership.
“We did find evidence that there were more principal investigators receiving funding for cancer research in the 2009-2010 period when compared with the 2005-2006 period and this growth in capacity bodes well for future cancer research activity.”
The survey captures information from 40 organizations or programs across the country involved in cancer research. It is designed to help optimize research investment by addressing gaps, reducing duplication and fostering opportunities for collaboration. “The investment survey is a valuable source of information for cancer research funders and an integral part of the pan-Canadian cancer research strategy,” says Dr. Eisenhauer.
This year’s report also describes shifts in the distribution of research funding by cancer type including a significant growth in investment in pancreatic cancer, a cancer with a very poor survivor outlook. As well, investment in bladder, lung and esophageal cancer research has more than doubled since 2005.
Find out more
To order copies of the 2010 report, download it in PDF or PowerPoint form, or get detailed information about the survey methodology please visit the Canadian Cancer Research Alliance (CCRA) website.
The CCRA is an alliance of more than 30 organizations involved in funding cancer research. The Executive Office of the CCRA is supported by the Partnership.
 The Canadian Cancer Research Survey captures most of the peer-reviewed research from the voluntary and government sectors. It does not include all sources of funding.